Similar medications and substitutes for evolocumab
In short: Repatha (evolocumab) belongs to the PCSK9 Inhibitors class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Repatha is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Repatha in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.